Mike Pool, the director of global health for the Bill and Melinda Gates Foundation, is joining Biomatics to focus on investments in nurology companies. (Photo courtesy of Biomatics Capital)
Biomatics Capital, a venture capital firm founded by two Seattle investors with close ties to philanthropists Bill and Melinda Gates, has raised another huge fund to invest in new healthcare and life sciences startups.
The firm’s second fund totals $300 million and will be invested in 15-20 companies developing healthcare innovations. The investments will be in “transformational innovation at the intersection of healthcare and technology,” the company said.
Biomatics also added a notable partner: Dr. Mike Pool, the head of global health at the Bill and Melinda Gates Foundation and a former neurological executive at AstraZeneca and Pfizer.
Pool will focus on “data- and genomics-enabled approaches to diagnose and treat neurological disorders” in his new role, potentially an indication that the firm is interested in Alzheimer’s work. Pool worked with Bill Gates on his recent support of Alzheimers work.
Errik Anderson, a Boston-based biotech entrepreneur and investor, also joined Biomatics as a new partner. The two new additions are the first partners to join the firm.
Julie Sunderland, co-founder and managing partner at Biomatics Capital Partners and previously director of program related investments for the Bill & Melinda Gates Foundation. (Biomatics Capital Photo)
“We are at an inflection point today in the development of new therapeutics and diagnostics, with a growing trove of data that will lead to improvements across healthcare, from drug discovery to clinical practice,” Julie Sunderland, the firm’s co-founder and managing partner, said in a press release. Sunderland was the director of program related investments for the Bill & Melinda Gates Foundation prior to co-founding Biomatics.
“With the addition of Mike and Errik, we will continue to combine the best of science with …read more